Indivior Pharmaceuticals Inc. Common Stock vs Vicor Corporation Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Vicor Corporation Common Stock trades at $240 (market cap $12.30B). The key difference: Vicor Corporation Common Stock is far larger — about 2.9× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Indivior Pharmaceuticals Inc. Common Stock is more actively traded (1,819,746 versus 1,052,269). Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Vicor Corporation Common Stock for 0 Days on average.
| INDV | VICR | |
|---|---|---|
Market Cap | $4.18B | $12.30B |
Volume | 1,819,746 | 1,052,269 |
Sector | Health | Technology |
52-Week High | $41.83 | $379.78 |
52-Week Low | $24.09 | $57.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.47B | $11.86B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →Vicor Corporation designs, manufactures, and markets modular power components and complete power systems, serving high-performance computing, data center, industrial, automotive, and aerospace and defense markets.
Read more on VICR →